Neil Harris Blumenthal

Neil Harris Blumenthal (Co-CEO) sold 63,040 shares of WRBY at $30.03 under pre-arranged 10b5-1 plan; stock now $24.50.

Neil Harris Blumenthal sold 63,040 shares (-55.7% vs pre-transaction holdings) on 2026-05-19 at $30.03 under a pre-arranged 10b5-1 trading plan adopted on 2025-09-16, making this a scheduled transaction rather than a discretionary choice. The current price of $24.50 is -21.0% from the 52-week high of $31.00, and the stock is down 2.6% over 30 days. Across his cross-ticker track record, his prior 20 sells averaged -2.7% return over 30 days and -14.5% over 90 days, while at WRBY specifically his 5 prior trades showed mixed near-term performance ranging from -5.8% to +19.3% at 30 days. The company reports $242.4M revenue in the latest quarter with +13.0% annual growth, but carries a P/E of 2450.00 on net income of $3.2M, signaling thin profitability relative to valuation.

WRBY Co-CEO Blumenthal sells 100,000 shares for $2.5M; pattern mirrors five prior well-timed exits at ticker.

Neil Harris Blumenthal, Co-Chief Executive Officer of Warby Parker, executed 4 separate sales totaling 100,000 shares for $2,467,129.65 between April 16–20, 2026, reducing his holdings by 66.6% to 50,165 shares. This sale is part of a measurable pattern: Blumenthal's 5 prior trades at WRBY (December 2025–January 2026) each generated negative 90-day returns ranging from −2.0% to −21.8%, with all 5 well-timed at the 90-day mark. His cross-ticker track record across 20 prior sells shows an 80.00% well-timed rate. The current stock price of $25.89 sits −14.4% below the 52-week high of $30.23, though up 14.1% over 30 days. Valuations remain stretched (P/E of 129.45), and near-term momentum is positive, but the insider's demonstrated ability to exit prior to downturns warrants investor attention to potential near-term consolidation or headwinds not yet reflected in current price action.

Co-CEO Blumenthal sold 50,000 WRBY shares at $27.08 on 2026-01-07; post-sale holdings 37,119 shares (-57.4% reduction).

Blumenthal sold 50,000 shares of Warby Parker at $27.08, reducing his holdings by 57.4% from 87,119 to 37,119 shares in a single transaction worth $1,354,000.00. This follows a pattern of four recent sells at the same ticker on 2026-01-06 and 2025-12-11, with only one prior measurable outcome at WRBY (a 2025-09-11 sale that showed +7.4% 90-day return, indicating the stock rose after sale). At the broader cross-ticker level, the insider's 20 prior sells averaged +0.8% over 90 days with a 68.75% well-timed rate, suggesting his sales have historically preceded modest gains rather than declines. The company's current valuation (P/E of 2830.00) reflects very limited profitability; Q4 revenue of $221.7M yielded only $5.9M net income, and the full fiscal year was unprofitable. The stock is trading 6.4% below its 52-week high and down 4.3% over 30 days despite a 27.1% 90-day gain.

Co-CEO Blumenthal sells 150,000 WRBY shares across 3 tranches for $3,763,500 on 2026-01-06

Neil Harris Blumenthal, Co-Chief Executive Officer, executed 3 separate sales totaling 150,000 shares for $3,763,500.00 at an average price of $25.09 per share on 2026-01-06, reducing his holdings to 37,119 shares post-transaction from 187,119 shares pre-transaction (an -80.2% reduction). The stock currently trades at $25.94, up 38.2% over the prior 30 days and 5.4% over 90 days from lower levels. At the same ticker, Blumenthal's 4 prior measurable sells show mixed 90-day outcomes (3 of 4 were well-timed with negative returns following the sale, though one prior sale on 2025-09-11 saw a +7.4% 90-day return). The company carries a notably elevated P/E of 2594.00 despite recent revenue growth of 15.2%; full-year net income was negative, though the latest quarter reported $5,874,000.00 in net income. A FLAG notes this filing contains a derivative-conversion transaction with Table II positions not yet populated in the database, so the 37,119 shares post-transaction do not necessarily represent the insider's total economic position.

Co-CEO Blumenthal sells 100,000 WRBY shares at $30.29; holdings drop -72.9% to 37,119 shares

Co-Chief Executive Officer Neil Harris Blumenthal sold 100,000 shares of Warby Parker at $30.29 on 2025-12-11, reducing his post-transaction holdings to 37,119 shares—a 72.9% reduction from the prior 137,119 shares. The sale occurred near the stock's 52-week high of $30.23, and the stock has since declined 11.2% to a current price of $26.84. Blumenthal's track record at WRBY shows 4 of 5 prior sells were well-timed at the 90-day mark, suggesting a pattern of exiting before downturns; however, his most recent same-ticker sell on 2025-09-11 showed a 90d return of +7.4%, breaking that pattern. The company remains unprofitable on a full-year basis despite posting $221.7M in latest-quarter revenue and 15.2% annual revenue growth, resulting in an elevated P/E of 2684.00. The sustained reduction in holdings by the co-CEO warrants attention given the company's profitability challenges and the material size of the transaction.

Co-CEO Blumenthal sells 41,084 WRBY shares at $27.53; retains 32,733 post-transaction following derivative conversion.

Blumenthal sold 41,084 shares (41.1K shares) at $27.53 on 2025-09-11 for $1,131,042.52 ($1.1M), reducing his holdings from 73,817 to 32,733 shares (-55.7% vs pre-transaction holdings). This sale occurred as part of a derivative-conversion transaction, meaning the insider's full economic position extends beyond the Table I shares reported here. At his prior WRBY sales on 2025-08-13, 2025-07-21, and 2025-07-18, the stock subsequently rose by +6.5%, +9.7%, and +13.0% over 30 days respectively—indicating that his recent transaction pattern at this ticker has been poorly timed. The company reported revenue of $214,475,000.00 ($214.5M) in the latest quarter but posted a net loss of $-1,752,000.00 ($-1.8M), with annual revenue growth of +15.2% despite remaining unprofitable over its most recent full fiscal year. The stock currently trades at $26.36, down 7.2% from its 52-week high of $28.42, whereas it traded at $27.53 on the transaction date. An investor should note that this sale is not a full position exit due to the derivative-conversion component; the insider's derivative holdings (Table II) would provide the complete picture of his remaining economic exposure.

Co-CEO Blumenthal sells 50,000 WRBY shares ($1.3M) at $25.11; retains 28,347 shares. Prior WRBY sales 90d well-timed; stock up 52.6% in 90 days.

Blumenthal sold 50,000 shares ($1.3M) on 2025-08-13 at $25.11, reducing his holdings from 78,347 to 28,347 shares. His prior three sales at Warby Parker were well-timed at the 90-day mark (posting -31.5%, -26.6%, and -24.5% respective returns), suggesting consistent ability to identify local peaks; however, the current transaction was executed as the stock entered strong momentum, with a 52.6% 90-day gain and a 16.5% 30-day gain following the sale date. This sale contradicts his own pattern of selling into weakness rather than strength. The company remains unprofitable despite 15.2% annual revenue growth, adding fundamental ambiguity around the valuation at which the sale occurred. A FLAG indicates derivative-conversion activity, meaning his Table I shares_after (28,347) do not represent his complete economic position, limiting the visibility into his net exposure.

Co-CEO Blumenthal sold 50,000 shares (50.0K shares) for $1,210,420.00 across 2 transactions; historical pattern: 5 of 5 prior WRBY sales well-timed at 90d mark

Neil Harris Blumenthal executed 2 separate sales totaling 50,000 shares for $1,210,420.00 on 2025-07-18 and 2025-07-21, reducing his holdings from 78,347 to 28,347 shares (a 63.8% reduction in pre-transaction holdings). At the same ticker, Blumenthal has demonstrated a strong pattern: all 5 of his prior WRBY sales were well-timed at the 90-day horizon, with negative 90-day returns ranging from -8.7% to -40.2%, indicating he has consistently sold before subsequent declines. The current stock price of $24.58 is 13.5% below the 52-week high of $28.42, and the 30-day momentum is strong at +13.1%, while the 90-day move is +64.8%. The company posted revenue of $223,782,000.00 in the latest quarter and reported annual revenue growth of +15.2%, but remains unprofitable on a full-year basis. The transaction's significance stems from both the scale of the stake reduction and the insider's demonstrated accuracy in timing sales at this specific ticker.

Co-CEO Blumenthal sells 177,967 shares ($4.3M) at $24.26 avg; retains 23,961 shares post-sale

Neil Harris Blumenthal, Co-Chief Executive Officer of Warby Parker, executed 3 separate sales on March 3-4, 2025, totaling 177,967 shares for $4,317,541.94 at a blended average price of $24.26. This represents a -88.1% reduction in his shareholdings from 201,928 shares to 23,961 shares. The current stock price is $23.50, only 3.1% below his blended transaction price, placing the sales near recent market levels. At the same-ticker level, his 5 prior WRBY sales show mixed near-term outcomes (ranging -10.4% to +12.5% at 30 days), with no 90-day measurable results yet. Notably, the company remains unprofitable (net income of $-4.1M in the latest quarter, full-year FY was negative) despite posting 15.2% annual revenue growth, and trades at a P/E ratio of 261.11. The magnitude of this sale—reducing his direct open-market holdings by 88.1%—coupled with ongoing operational losses, warrants investor attention to the underlying business trajectory and executive confidence signals.

Co-CEO Blumenthal sells 50,000 WRBY shares at $27.61; retains 12,177 post-transaction via derivative conversion.

On 2025-01-30, Neil Harris Blumenthal, Co-Chief Executive Officer, sold 50,000 shares of Warby Parker Inc. (WRBY) for $1,380,500.00 at $27.61 per share, reducing his direct holdings to 12,177 shares—an 80.4% reduction in the reported position. The filing contains a derivative-conversion transaction flag, indicating the Table I share count does not represent the full position; real holdings are recorded in Table II (derivatives), which remains unpopulated. Prior sales at WRBY show mixed near-term results: 30-day returns ranged from -2.0% to +12.5%, with no measurable 90-day outcomes yet available. Across all tickers, Blumenthal's broader sell track record shows an average 90d return of +35.2%, meaning the stock typically rose after his sales—a pattern of poorly-timed exits. The company remains unprofitable (net income: $-4.1M on $192.4M quarterly revenue), trading within its 52-week range and only 3.8% from the 52-week high. The sale should be evaluated as a partial liquidation of Table I holdings within a broader derivative position, not a comprehensive portfolio exit.